Company Overview of Chiesi USA, Inc.
Chiesi USA, Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of prescription pharmaceutical drugs for the hospital and adjacent specialty markets. The company offers CARDENE I.V., a premixed injection for the short-term treatment of hypertension; CUROSURF, a natural lung surfactant for the treatment of respiratory distress syndrome in premature infants; and ZYFLO, a leukotriene synthesis inhibitor for prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. It also provides BETHKIS, an inhaled tobramycin-based product for the management of cystic fibrosis patients with pseudomonas aeruginosa; and hyd...
1255 Crescent Green Drive
Cary, NC 27518
Key Executives for Chiesi USA, Inc.
Chairman and Chief Executive Officer
Chief Financial Officer and Vice President of Finance
Principal Accounting Officer and Director of Accounting, Financial Planning & Analysis
Vice President of Clinical and Regulatory
Compensation as of Fiscal Year 2015.
Chiesi USA, Inc. Key Developments
Chiesi USA, Inc. Presents at BIO-Europe 2015, Nov-02-2015
Oct 1 15
Chiesi USA, Inc. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.
Chiesi USA, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015
Dec 24 14
Chiesi USA, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.
Chiesi USA, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014
Sep 10 14
Chiesi USA, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 . Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|